Millennium Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,100
Closed -$1.65M 6274
2025
Q4
$1.65M Sell
10,100
-65,000
-87% -$10.2M ﹤0.01% 4101
2025
Q3
$10M Buy
+75,100
New +$9.12M ﹤0.01% 2379
2024
Q4
Sell
-53,600
Closed -$7.98M 6387
2024
Q3
$7.98M Buy
53,600
+3,100
+6% +$445K ﹤0.01% 2401
2024
Q2
$6.37M Buy
+50,500
New +$7.92M ﹤0.01% 2492
2023
Q3
Sell
-5,200
Closed -$736K 6488
2023
Q2
$736K Sell
5,200
-14,800
-74% -$2.37M ﹤0.01% 4269
2023
Q1
$3.37M Sell
20,000
-66,000
-77% -$11.8M ﹤0.01% 2958
2022
Q4
$14.6M Buy
+86,000
New +$15.6M 0.01% 1741
2022
Q3
Sell
-32,000
Closed -$5.2M 7420
2022
Q2
$5.2M Buy
+32,000
New +$5.06M ﹤0.01% 2767

Other funds holding RGEN

Millennium Management's RGEN Position: Q1 2026 in Review

Millennium Management reduced its Repligen (RGEN) stake by 97% in Q1 2026, selling an estimated $87.7M and leaving 22,461 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3601.

Millennium Management first reported a position in RGEN in Q2 2013 and has held it in 43 quarters since. The position peaked at $109M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Millennium Management held 22,461 shares of Repligen worth $2.65M as of Q1 2026.
  • Millennium Management sold 628,085 Repligen shares in Q1 2026, an estimated $87.7M.
  • Repligen made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3601 holding.
  • Millennium Management first reported a position in Repligen in Q2 2013 and has held it in 43 quarters since.
  • Millennium Management's Repligen position peaked at $109M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.